News
-
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
-
Water Ways Announces Corporate Updates
-
Digi Power X Announces Upsizing of At-the-Market Offering Program
-
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
-
Sekur Private Data Advances Defense-Grade Secure Communications Platform
-
EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
-
EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
-
Metall Zug – Annual General Meeting of Shareholders approves all proposals
-
Designated Person Notification
-
Designated Person Notification
-
2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
-
Disclosure of Share Capital and Voting Rights as of April 30, 2026
-
Déclaration du nombre d’actions et droits de vote au 30 avril 2026
-
ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL